Arkolith/Insider Trading/CLVS/Form 4

Rolfe Lindsey

See RemarksClovis Oncology, Inc. (CLVS) · full profile →Form 4 · filed Jun 3, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2022Sell(S)3K$0.64$2K103K
Jun 1, 2022Option exercise(M)5K——106K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2022Option exercise(M)5K—$056K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-020946) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML